BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32917523)

  • 1. Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis.
    Tashiro H; Takahashi K; Kurihara Y; Sadamatsu H; Kimura S; Sueoka-Aragane N
    Allergol Int; 2021 Jan; 70(1):145-147. PubMed ID: 32917523
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
    Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
    J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment.
    Tomomatsu K; Sugino Y; Okada N; Tanaka J; Oguma T; Asano K
    Allergol Int; 2020 Oct; 69(4):636-638. PubMed ID: 32247541
    [No Abstract]   [Full Text] [Related]  

  • 4. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
    Wolf BL; Johnson A
    J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergic bronchopulmonary aspergillosis successfully treated with benralizumab.
    Soeda S; Kono Y; Tsuzuki R; Yamawaki S; Katsube O; To M; To Y
    J Allergy Clin Immunol Pract; 2019; 7(5):1633-1635. PubMed ID: 30513359
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
    Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
    Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.
    Donato AA; Krol R
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30765445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of allergic bronchopulmonary aspergillosis with central bronchiectasis over a 10-year period: the need to recheck allergen sensitization.
    Yoshida Y; Shirai T; Mikamo M; Shishido Y; Akita T; Morita S; Asada K; Fujii M; Suda T
    Intern Med; 2013; 52(18):2135-8. PubMed ID: 24042528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological analysis of sensitization in allergic bronchopulmonary aspergillosis: a study on allergen components and interspecies relationships.
    Kuwabara K; Hirose M; Kato K; Yokoi T; Shiga M; Kondo R; Nakamura M; Matsunaga K; Horiguchi T
    J Asthma; 2020 Jun; 57(6):610-617. PubMed ID: 30943819
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis.
    Agarwal R; Gupta D; Aggarwal AN; Saxena AK; Saikia B; Chakrabarti A; Jindal SK
    Respir Med; 2010 Feb; 104(2):204-10. PubMed ID: 19800210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiological signs of ABPA associated with airways infection with Aspergillus in the absence of specific IgE.
    Sunzini F; Barbato C; Canofari C; Lugari L; Perricone R; Bergamini A
    Eur Ann Allergy Clin Immunol; 2016 Sep; 48(5):202-4. PubMed ID: 27608478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
    Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
    BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic Bronchopulmonary Aspergillosis.
    Reddy A; Greenberger PA
    J Allergy Clin Immunol Pract; 2017; 5(3):866-867. PubMed ID: 28483324
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
    Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.
    Soeda S; To M; Kono Y; Yamawaki S; Tsuzuki R; Katsube O; Watanabe N; To Y
    Allergol Int; 2019 Jul; 68(3):377-379. PubMed ID: 30704844
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
    Altman MC; Lenington J; Bronson S; Ayars AG
    J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic bronchopulmonary aspergillosis: an Indian perspective.
    Shah A
    Curr Opin Pulm Med; 2007 Jan; 13(1):72-80. PubMed ID: 17133129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis.
    Pacheco A; Martin JA; Cuevas M
    Chest; 1993 Mar; 103(3):980-1. PubMed ID: 8383593
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis.
    Agarwal R; Dua D; Choudhary H; Aggarwal AN; Sehgal IS; Dhooria S; Garg M; Behera D; Chakrabarti A
    Mycoses; 2017 Jan; 60(1):33-39. PubMed ID: 27523578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 65-Year-Old Woman With a Wheeze.
    Menon DP; Patel NM
    Mayo Clin Proc; 2019 Mar; 94(3):e39-e44. PubMed ID: 30713049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.